...
首页> 外文期刊>Journal of Medical Sciences >Correlation of Serum Free/Total Prostate Specific Antigen Ratio with Histological Features for Differential Diagnosis of Prostate Cancer
【24h】

Correlation of Serum Free/Total Prostate Specific Antigen Ratio with Histological Features for Differential Diagnosis of Prostate Cancer

机译:血清游离/总前列腺特异性抗原比率与组织学特征对前列腺癌鉴别诊断的相关性

获取原文

摘要

This study sought to find the correlation between Free to TPSA (F/T PSA) ratio and the histological grades of prostate cancer. Among 120 selected from both in-patients and out-patient clinic of the urology unit, 51 underwent tissue biopsies within six months of their PSA measurements using enzyme immunoassay. The F/T PSA ratios of patients with prostate cancer were compared to those with BPH, using the students` t-test. Correlation between histology grades and F/T PSA ratios was calculated by the Pearson test and linear regression. Receiver Operating Characteristic (ROC) curves were generated from sensitivities and specificities of various F/T PSA ratios, FPSA and TPSA levels. The F/T PSA ratio was significantly lower in the group of patients with prostate cancer (PCa) (0.118 ± 0.0043) compared to BPH (0.302 ± 0.0179, p2 = 0.76, p<0.0001), that is, the higher the histology grade, the lower the F/T PSA ratio. The best accuracy was obtained with F/T PSA ratio cut-off at 0.15, with specificity of 87.50% and sensitivity of 100%. The use of the F/T PSA ratio improves PSA-based differential diagnoses of prostate cancer in patients and can also lead to more specific identification of potentially curable prostate cancer and reduce unnecessary prostate biopsies.
机译:这项研究试图找到Free to TPSA(F / T PSA)比与前列腺癌的组织学等级之间的相关性。从泌尿科的住院和门诊中选出的120名患者中,有51名在使用酶免疫法进行PSA测量后的六个月内进行了组织活检。使用学生t检验比较了前列腺癌患者与BPH患者的F / T PSA比值。通过皮尔逊检验和线性回归计算组织学等级与F / T PSA比之间的相关性。接收器工作特性(ROC)曲线是由各种F / T PSA比值,FPSA和TPSA水平的敏感性和特异性得出的。与BPH(0.302±0.0179,p2 = 0.76,p <0.0001)相比,前列腺癌(PCa)组的F / T PSA比明显降低(0.118±0.0043)。组织学等级越高,F / T PSA比越低。 F / T PSA比率截止值为0.15,可获得最佳精度,特异性为87.50%,灵敏度为100%。 F / T PSA比值的使用改善了患者基于PSA的前列腺癌的鉴别诊断,并且还可以导致更具体地鉴定可能治愈的前列腺癌并减少不必要的前列腺活检。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号